Increasing Transparency - Transfers of Value to Healthcare Professionals and Organisations
Novartis collaborates with Healthcare Professionals and Healthcare Organisations to advance patient care and is committed to openly communicating transfers of value related to these relationships.
Increasing Transparency, what you should know
Collaborative working between healthcare professionals and pharmaceutical companies has long been a driver for advancements in patient care and innovative medicine.
What?
The type of collaborations include:
- Clinical trials and research
- Grants
- Patient education and awareness initiatives
- Attendence at scientific congresses, educational meetings, advisory boards
- Training
Both parties regularly collaborate during early scientific research, clinical trials and medical education in the interest of delivering and advancing high quality patient care.
Who?
This relates to all healthcare professionals (e.g. clinicians, GPs, nurses) and their organisations (e.g. hospitals).
IPHA (Irish Pharmaceutical Healthcare Association) makes public details of certain transfers of value (i.e. payments/benefits in kind) made to healthcare professionals and their organisations.
Novartis Ireland has a strong commitment to ethical and transparent collaboration with healthcare professionals.
For more information, please go to www.transferofvalue.ie, The EFPIA Code or https://www.novartis.com/esg/reporting/transparency-and-disclosure/paym…;